Two CHOP Studies Find Role for ALT in Treatment-Resistant CNS Tumors
Published on
Two recent papers from CHOP cancer researchers have advanced the understanding of treatment-resistant pediatric central nervous system tumors.
Refractory Neuroblastoma Program News and Updates
1 - 10 of 17
Researchers Show Lorlatinib is Safe, Effective for Patients with High-Risk Neuroblastoma
Published on
CHOP researchers have shown that adenovirus proteins use a process called phase separation to coordinate production of viral progeny, which could have broad implications.
CHOP Researchers Show Liquid Biopsies Can Catch Disease Progression Early in High-Risk Neuroblastoma
Published on
CHOP researchers found that a series of “liquid biopsies” could less invasively and more accurately identify tumor changes in patients with high-risk neuroblastoma.
CHOP Researchers Join Global Team to Take on Solid Tumors in Children
Published on
Four CHOP researchers are part of a world-class research team that will receive $25 million to study solid tumors in children, funded by Cancer Grand Challenges.
CHOP Brings Together Experts to Discuss Precision Medicine in Pediatric Cancer Care
Published on
More than 250 experts gathered in Philadelphia and virtually to discuss the latest scientific advancements and breakthroughs in pediatric precision medicine oncology.
CHOP Researchers Develop a New Class of CAR-T Cells that Target Previously Untargetable Cancer Drivers
Published on
CHOP researchers have developed a novel cancer therapy that targets proteins inside cancer cells that are essential for tumor growth and survival but have been historically impossible to reach.
CHOP Cancer Researchers Win 2021 AACR Team Science Award
Published on
The award was presented to the St. Baldrick’s Foundation-Stand Up 2 Cancer Pediatric Cancer Dream Team, co-led by CHOP, at the annual AACR conference.
CHOP Researchers Awarded Crazy 8 Grant from Alex’s Lemonade Stand Foundation
Published on
CHOP researchers will receive funds to discover a new drug that targets MYCN, a transcription factor involved in some pediatric cancers.
Yael Mossé, MD, Featured by the Conquer Cancer Foundation
Published on
The CHOP physician-researcher’s investigation into cause of and treatment for neuroblastoma has been supported by Conquer Cancer grants.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.